Ondansetrn ODT 4MG 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FX0GD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,870
Award facts
- Contract value 100% obligated
- $13,870.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $13,870.42 from the Defense Logistics Agency (DLA) on January 29, 2026, for Ondansetron Orally Disintegrating Tablets 4mg in a 30-count package. The award is a firm fixed-price contract with an ultimate completion date of February 26, 2026, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
The DLA Medical Supply Chain relies on strategic partnerships with major pharmaceutical distributors like Cencora/AmerisourceBergen to ensure the availability of critical medications across multiple therapeutic domains for military treatment facilities and veterans' healthcare programs. Ondansetron, an antiemetic commonly used in military medical settings to prevent nausea and vomiting, exemplifies the routine pharmaceutical commodities procured through this established contract vehicle. The firm fixed-price structure and expedited completion timeline reflect the DLA's need for rapid deployment of essential medical supplies to support operational readiness and healthcare delivery across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FX0GD?
SPE2DR26FX0GD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FX0GD worth?
The government has obligated $13,870 on SPE2DR26FX0GD.
Is contract SPE2DR26FX0GD an order under another contract?
Yes. SPE2DR26FX0GD is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX0GD competed?
The extent of competition for SPE2DR26FX0GD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award